Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4824 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36132 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2560-0266 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2505-09 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36175 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3615 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-1104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
filingDate |
2020-06-15^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebc2f01b2678356116946c5151cfa60e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c61d66ec6239224a2059a625e6db4d2e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f618995d0eace5bdbd3feab85e4e4160 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1b307d57968c33bb3be1fa8b8b25f62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_beba27a3112b439c9a9dd665d4f870d9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41452703be06a6d75ab0e17b1567404e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2246fbfe099f7cd32afc00544c32430 |
publicationDate |
2022-06-01^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-4003494-A1 |
titleOfInvention |
Titration for sub-threshold electrical stimulation therapy |
abstract |
In some examples, a medical device is configured to deliver sub-threshold electrical stimulation therapy to a patient at a stimulation intensity that is significantly less than a perception or paresthesia threshold intensity level for the patient. The medical device may determine the particular intensity level for the patient through a titration process. The medical device may titrate automatically or based upon the input of the patient, a clinician or a physician. |
priorityDate |
2019-07-30^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |